We are 225,716 members in 82 forums discussing 158,418 topics.

Help with Abbreviations

Topic: The ELAINE study is recruiting (Lasofoxifene). Read here.

Forum: Clinical Trials, Research News, Podcasts, and Study Results —

Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.

Posted on: Dec 10, 2019 06:27PM - edited Dec 10, 2019 06:30PM by Moderators

Moderators wrote:

The ELAINE study is evaluating an investigational oral drug, Lasofoxifene, in postmenopausal women diagnosed with locally advanced or metastatic estrogen-receptor-positive, HER2-negative breast cancer with an ESR1 mutation who have had the cancer grow while being treated with an aromatase inhibitor in combination with a CDK4/6 inhibitor.

People are eligible to participate in the ELAINE study if they:

are postmenopausal women

have been diagnosed with locally advanced or metastatic estrogen-receptor-positive, HER2-negative breast cancer with an ESR1 mutation

have had the cancer grow while being treated with an aromatase inhibitor in combination with a CDK4/6 inhibitor

The ELAINE trial is being conducted at multiple sites around the United States.

For more information, to find a trial site near you, or to enroll, visit the ELAINE Trial page on Breastcancer.org:https://www.breastcancer.org/treatment/clinical_trials/featured/elaine

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply